Fuelling the Next Generation of ADCs: Protein Alkylation Payloads & the Broader ADC Innovation Imperative

• Highlighting the strategic need for diversified payload platforms to drive sustainable ADC pipeline growth and maintain market competitiveness
• Positioning protein alkylation as a differentiated and emerging modality within the evolving ADC payload landscape
• Showcasing the unique mechanism of action and therapeutic potential of Iksuda Therapeutics’ ProAlk™ payload

Speakers:

Bob Lutz

Chief Scientific Officer

Iksuda Therapeutics